Gujarat Terce Laboratories Ltd vs Zenith Health Care Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 17, 2026

Key Highlights

The Latest Trading Price of Gujarat Terce Laboratories Ltd is ₹ 36.48 as of 15 May 15:30 . The P/E Ratio of Gujarat Terce Laboratories Ltd changed from 22.2 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Zenith Health Care Ltd changed from 70.9 on March 2021 to 418 on March 2025 . This represents a CAGR of 42.60% over 5 years The Market Cap of Gujarat Terce Laboratories Ltd changed from ₹ 5.16 crore on March 2021 to ₹ 45.37 crore on March 2025 . This represents a CAGR of 54.46% over 5 yearsThe Market Cap of Zenith Health Care Ltd changed from ₹ 30.47 crore on March 2021 to ₹ 22.46 crore on March 2025 . This represents a CAGR of -5.92% over 5 years The revenue of Gujarat Terce Laboratories Ltd for the Dec '25 is ₹ 12.42 crore as compare to the Sep '25 revenue of ₹ 12.98 crore. This represent the decline of -4.31% The revenue of Zenith Health Care Ltd for the Dec '25 is ₹ 2.53 crore as compare to the Sep '25 revenue of ₹ 2.38 crore. This represent the growth of 6.3% The ebitda of Gujarat Terce Laboratories Ltd for the Dec '25 is ₹ 1.26 crore as compare to the Sep '25 ebitda of ₹ 1.94 crore. This represent the decline of -35.05% The ebitda of Zenith Health Care Ltd for the Dec '25 is ₹ 0.32 crore as compare to the Sep '25 ebitda of ₹ 0.28 crore. This represent the growth of 14.29% The net profit of Gujarat Terce Laboratories Ltd changed from ₹ -0.08 crore to ₹ 0.76 crore over 7 quarters. This represents a CAGR of NaN% The net profit of Zenith Health Care Ltd changed from ₹ 0.16 crore to ₹ 0.22 crore over 7 quarters. This represents a CAGR of 19.96% The Dividend Payout of Gujarat Terce Laboratories Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zenith Health Care Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Gujarat Terce Laboratories Ltd

Gujarat Terce Laboratories Limited, incorporated in 1985, is a trusted manufacturer of high quality medication at affordable rates for the common man.
Company specialise in producing oral solid dosages, including tablets and capsules, that address various therapeutic needs. Headquartered in Ahmedabad, Gujarat, Terce offers an extensive portfolio featuring over 125 products and more than 64 well-established brands. By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing.
In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange.
In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat.
As India heralded new leaps in the pharma sector to become a global force to reckon with by 2005, the Company closely followed the narrative with ferocious growth expanding presence in the domestic and international market.

About Zenith Health Care Ltd

Zenith Healthcare Limited, incorporated in 1994, is an ISO 9001:2008 & WHO-cGMP certified company, which is strategically located in Changodar, from Ahmedabad International Airport and 20 km from the main city of Ahmedabad in Gujarat which is the hub of Indian Pharmaceutical Industry.
The Company is engaged into manufacturing of tablets, capsules, ointments, and liquid injectable among others. The Company is a fully integrated, global healthcare provider, with a core competence in the field of healthcare.
It provides total healthcare solutions ranging from formulations, active pharmaceutical ingredients,animal healthcare products and to various wellness products.
It has its manufacturing facilities located at Changodar, Gujarat with installed capacity to manufacture 168 million tablets, 39.

FAQs for the comparison of Gujarat Terce Laboratories Ltd and Zenith Health Care Ltd

Which company has a larger market capitalization, Gujarat Terce Laboratories Ltd or Zenith Health Care Ltd?

Market cap of Gujarat Terce Laboratories Ltd is 28 Cr while Market cap of Zenith Health Care Ltd is 16 Cr

What are the key factors driving the stock performance of Gujarat Terce Laboratories Ltd and Zenith Health Care Ltd?

The stock performance of Gujarat Terce Laboratories Ltd and Zenith Health Care Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gujarat Terce Laboratories Ltd and Zenith Health Care Ltd?

As of May 17, 2026, the Gujarat Terce Laboratories Ltd stock price is INR ₹36.48. On the other hand, Zenith Health Care Ltd stock price is INR ₹3.05.

How do dividend payouts of Gujarat Terce Laboratories Ltd and Zenith Health Care Ltd compare?

To compare the dividend payouts of Gujarat Terce Laboratories Ltd and Zenith Health Care Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.